Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 381-389 , May 2010

Prognostic Significance of Acute Kidney Injury After Reperfused ST-Elevation Myocardial Infarction: Synergistic Acceleration of Renal Dysfunction and Left Ventricular Remodeling

  • Atsushi Anzai, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Toshihisa Anzai, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • Corresponding Author InformationReprint requests: Toshihisa Anzai, MD, FACC, Division of Cardiology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: + 81-3-5363-3793, Fax: + 81-3-3353-2502
  • ,
  • Kotaro Naito, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Hidehiro Kaneko, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Yoshinori Mano, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Yusuke Jo, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Yuji Nagatomo, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Yuichiro Maekawa, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Akio Kawamura, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Tsutomu Yoshikawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Satoshi Ogawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Received 19 June 2009 ,Revised 18 December 2009 ,Accepted 30 December 2009.

References 

  1. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–1295
  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  3. Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation. 2004;110:3667–3673
  4. Naito K, Anzai T, Yoshikawa T, Anzai A, Kaneko H, Kohno T, et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail. 2008;14:831–838
  5. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005;26:11–17
  6. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008;168:987–995
  7. Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168:609–616
  8. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31
  9. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150:1237–1242
  10. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–1785
  11. Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2006;2:80–91
  12. Brady HR, Singer GG. Acute renal failure. Lancet. 1995;346:1533–1540
  13. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448–1460
  14. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5–14
  15. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503–1520
  16. Fujii T, Kurata H, Takaoka M, Muraoka T, Fujisawa Y, Shokoji T, et al. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol. 2003;481:241–248
  17. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109:665–678
  18. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med. 2004;116:263–272
  19. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997;96:778–784
  20. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol. 2003;88:257–265
  21. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002;39:241–246
  22. Naito K, Anzai T, Yoshikawa T, Maekawa Y, Sugano Y, Kohno T, et al. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling. J Card Fail. 2007;13:25–33
  23. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248–254
  24. Flaherty JD, Udelson JE, Gheorghiade M, Wu E, Davidson CJ. Assessment and key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol. 2008;102:5G–12G
  25. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovascular research. 2009;81:482–490
  26. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–464
  27. Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med. 1976;295:1356–1362
  28. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–3370
  29. Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150:330–337
  30. Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003;24:412–420
  31. Eijkelkamp WB, de Graeff PA, van Veldhuisen DJ, van Dokkum RP, Gansevoort RT, de Jong PE, et al. Effect of first myocardial ischemic event on renal function. Am J Cardiol. 2007;100:7–12
  32. van Dokkum RP, Eijkelkamp WB, Kluppel AC, Henning RH, van Goor H, Citgez M, et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol. 2004;15:3103–3110
  33. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769–2775
  34. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805
  35. Schor N. Acute renal failure and the sepsis syndrome. Kidney Int. 2002;61:764–776
  36. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–169
  37. Nagaya N, Goto Y, Nishikimi T, Uematsu M, Miyao Y, Kobayashi Y, et al. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction. Clin Sci (Lond). 1999;96:129–136
  38. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol. 2003;14:1549–1558
  39. Molitoris BA, Levin A, Warnock DG, Joannidis M, Mehta RL, Kellum JA, et al. Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol. 2007;3:439–442
  40. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–2543
  41. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273:4135–4142
  42. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Critical care medicine. 2008;36:S159–S165
  43. Marenzi G, Assanelli E, Campodonico J, De Metrio M, Lauri G, Marana I, et al. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med. 2010;38:438–444

 Supported in part by the Medical School Faculty and Alumni Grant from Keio University Medical Science Fund (T.A.).

PII: S1071-9164(09)01240-8

doi: 10.1016/j.cardfail.2009.12.020

Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 381-389 , May 2010